Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MASLD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableStudy completedNCT06352697
What this trial is testing

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver DiseaseHepatic Steatosis
Bogomolets National Medical University 50
Not applicableNot Yet RecruitingNCT07475962
What this trial is testing

Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesLiver SteatosesMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
Institut de Recherches Cliniques de Montreal 100
Not applicableStudy completedNCT07478588
What this trial is testing

Structured Physical Activity Intervention in Patients With MASLD Receiving a Mediterranean Diet

Who this might be right for
MASLD
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 96
Not applicableEnrolling By InvitationNCT07312136
What this trial is testing

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseCirrhosisAdvanced Fibrosis+6 more
Linkoeping University 317
Not applicableUnknownNCT06490432
What this trial is testing

Pattern of Cardiac Arrhythmia in Patients With MASLD

Who this might be right for
Cardiac ArrhythmiaMetabolic Dysfunction Associated Steatotic Liver Disease
Sohag University 100
Not applicableLooking for participantsNCT07682363
What this trial is testing

Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians

Who this might be right for
Liver Disease
Novo Nordisk A/S 470
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07495995
What this trial is testing

SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Cedars-Sinai Medical Center 94
Not applicableStudy completedNCT06647095
What this trial is testing

New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
HealthySimple Steatosis (SS)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
General University Hospital, Prague 172
Not applicableNot Yet RecruitingNCT07764835
What this trial is testing

Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis B+2 more
D'Or Institute for Research and Education 300
Not applicableLooking for participantsNCT06867419
What this trial is testing

Metabolic Features Effects on FAST Score in MASLD Patients

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Tanta University 385
Post-approval studies (Phase 4)Active Not RecruitingNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Not applicableStudy completedNCT06047847
What this trial is testing

Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption

Who this might be right for
NAFLDMASLDMild Inflammatory Context
Valbiotis 10
Not applicableLooking for participantsNCT07382349
What this trial is testing

Electronic Clinical Decision Support Tools for Steatotic Liver Disease

Who this might be right for
MASLD
Vanderbilt University Medical Center 7,200
Not applicableNot Yet RecruitingNCT07585526
What this trial is testing

Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.

Who this might be right for
MASLDChronic Kidney Diseases
Institute of Liver and Biliary Sciences, India 160
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Not applicableLooking for participantsNCT06329544
What this trial is testing

High Fructose Diet, the Gut Microbiome, and Metabolic Health

Who this might be right for
MASLDType 2 DiabetesObesity
Icahn School of Medicine at Mount Sinai 30
Next Page